KLYG Stock Overview
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Kelyniam Global, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.042 |
| 52 Week High | US$0.095 |
| 52 Week Low | US$0.042 |
| Beta | -1.51 |
| 1 Month Change | -13.34% |
| 3 Month Change | -30.28% |
| 1 Year Change | -48.27% |
| 3 Year Change | -79.04% |
| 5 Year Change | -73.30% |
| Change since IPO | -84.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| KLYG | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -16.2% | 1.6% | 1.0% |
| 1Y | -48.3% | -1.4% | 21.9% |
Return vs Industry: KLYG underperformed the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: KLYG underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| KLYG volatility | |
|---|---|
| KLYG Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KLYG's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine KLYG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | Ross Bjella | www.kelyniam.com |
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial and maxilla-facial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors.
Kelyniam Global, Inc. Fundamentals Summary
| KLYG fundamental statistics | |
|---|---|
| Market cap | US$1.25m |
| Earnings (TTM) | -US$218.47k |
| Revenue (TTM) | US$2.67m |
0.5x
P/S Ratio-5.7x
P/E RatioIs KLYG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KLYG income statement (TTM) | |
|---|---|
| Revenue | US$2.67m |
| Cost of Revenue | US$636.28k |
| Gross Profit | US$2.04m |
| Other Expenses | US$2.25m |
| Earnings | -US$218.47k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0073 |
| Gross Margin | 76.19% |
| Net Profit Margin | -8.18% |
| Debt/Equity Ratio | 80.1% |
How did KLYG perform over the long term?
See historical performance and comparison